Market Cap 17.37M
Revenue (ttm) 10.91M
Net Income (ttm) -43.39M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -397.71%
Debt to Equity Ratio 0.00
Volume 60,400
Avg Vol 118,198
Day's Range N/A - N/A
Shares Out 10.46M
Stochastic %K 19%
Beta 3.60
Analysts Strong Sell
Price Target $17.00

Company Profile

Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small-molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single-arm expansion trial in patients with relapsed or refractory, or R/R, AML and high-risk myelodysplastic syndromes. The company's pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 503 6500
Address:
Building C, Suite 500 128 Spring Street, Lexington, United States
Topzero
Topzero Aug. 1 at 8:35 PM
$CRIS Believe me the company garbage Also, CEO Soon new TARGET 0
0 · Reply
LodiDodiWeLikesToParty
LodiDodiWeLikesToParty Jul. 31 at 11:26 AM
$CRIS I don't believe they even have a product anymore. Total silence. This has to be fraud.
0 · Reply
Topzero
Topzero Jul. 30 at 6:39 PM
$CRIS don’t believe this company believe me 6 years same story this is company cheats
0 · Reply
Topzero
Topzero Jul. 30 at 6:36 PM
$CRIS soon OTC
0 · Reply
Yodalay
Yodalay Jul. 30 at 1:39 PM
August 5, Q2 results $CRIS
0 · Reply
BallWasher69
BallWasher69 Jul. 28 at 9:53 AM
$CRIS two weeks or less until we receive a corporate update via their Q2 financial release….
0 · Reply
View2021
View2021 Jul. 23 at 3:15 AM
$CRIS breakout stock tomorrow $1.50
0 · Reply
baaaddbob
baaaddbob Jul. 22 at 3:47 PM
$CRIS most analysts expect this stock to go to $17 or above?.. ask chat gpt….. loaded up just now$$
0 · Reply
Topzero
Topzero Jul. 21 at 7:30 PM
$CRIS I told you before — this company is trash, and the stock will be split soon. Do not buy it! Beware, even if it goes up, it’s just a trap — their last desperate move to steal your money.”
0 · Reply
Topzero
Topzero Jul. 21 at 5:47 AM
$CRIS Advice to All Investors: If the stock price of Curis Inc. (CRIS) rises, do not rush to buy. Be cautious, as purchasing the stock during an upward movement may lead to it being “locked in” at a high price. This could allow the company to accumulate a significant amount of capital. Subsequently, the company might perform a stock split, which could benefit them at your expense. Avoid buying altogether to shift the responsibility entirely onto the company. Let them bear the burden of raising the stock price on their own. However, if you do buy shares and the price is lifted—only for the company to sell a large volume and then execute a stock split—the company will profit. The stock’s value may appear to multiply, but this could be a trap. Do not be deceived by the company’s actions. Insist that they take full responsibility for raising the stock price, and avoid falling into a scenario where their gains come at your loss.
0 · Reply
Latest News on CRIS
Curis, Inc. (CRIS) Q1 2025 Earnings Call Transcript

May 6, 2025, 2:40 PM EDT - 3 months ago

Curis, Inc. (CRIS) Q1 2025 Earnings Call Transcript


Curis Provides First Quarter 2025 Business Update

May 6, 2025, 8:00 AM EDT - 3 months ago

Curis Provides First Quarter 2025 Business Update


Curis to Present at Upcoming Healthcare Conference in April

Apr 2, 2025, 4:05 PM EDT - 4 months ago

Curis to Present at Upcoming Healthcare Conference in April


Curis, Inc. (CRIS) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 9:59 AM EDT - 4 months ago

Curis, Inc. (CRIS) Q4 2024 Earnings Call Transcript


Curis Provides Fourth Quarter 2024 Business Update

Mar 31, 2025, 8:00 AM EDT - 4 months ago

Curis Provides Fourth Quarter 2024 Business Update


Curis Announces Additional Data from TakeAim Leukemia Study

Dec 10, 2024, 8:00 AM EST - 8 months ago

Curis Announces Additional Data from TakeAim Leukemia Study


Curis, Inc. (CRIS) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 11:02 AM EST - 9 months ago

Curis, Inc. (CRIS) Q3 2024 Earnings Call Transcript


Curis Provides Third Quarter 2024 Business Update

Nov 14, 2024, 8:00 AM EST - 9 months ago

Curis Provides Third Quarter 2024 Business Update


Curis Announces the 3rd Annual Symposium on IRAK4 in Cancer

Sep 23, 2024, 8:30 AM EDT - 11 months ago

Curis Announces the 3rd Annual Symposium on IRAK4 in Cancer


Curis to Present at Upcoming Healthcare Conferences in September

Sep 4, 2024, 8:00 AM EDT - 11 months ago

Curis to Present at Upcoming Healthcare Conferences in September


Curis, Inc. (CRIS) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 3:44 PM EDT - 1 year ago

Curis, Inc. (CRIS) Q2 2024 Earnings Call Transcript


Curis to Present at Upcoming Healthcare Conference in July

Jul 10, 2024, 7:30 AM EDT - 1 year ago

Curis to Present at Upcoming Healthcare Conference in July


Curis to Present Updated Data from the TakeAim Leukemia Study

May 10, 2024, 8:00 AM EDT - 1 year ago

Curis to Present Updated Data from the TakeAim Leukemia Study


Curis, Inc. (CRIS) Q1 2024 Earnings Call Transcript

May 7, 2024, 8:08 PM EDT - 1 year ago

Curis, Inc. (CRIS) Q1 2024 Earnings Call Transcript


Curis Provides First Quarter 2024 Business Update

May 7, 2024, 8:00 AM EDT - 1 year ago

Curis Provides First Quarter 2024 Business Update


Curis to Present at Upcoming Healthcare Conferences in April

Apr 4, 2024, 7:30 AM EDT - 1 year ago

Curis to Present at Upcoming Healthcare Conferences in April


Curis, Inc. (CRIS) Q4 2023 Earnings Call Transcript

Feb 8, 2024, 2:04 PM EST - 1 year ago

Curis, Inc. (CRIS) Q4 2023 Earnings Call Transcript


Curis Provides Fourth Quarter 2023 Business Update

Feb 8, 2024, 8:00 AM EST - 1 year ago

Curis Provides Fourth Quarter 2023 Business Update


Curis Announces Three Presentations at ASH

Dec 6, 2023, 8:00 AM EST - 1 year ago

Curis Announces Three Presentations at ASH


Curis, Inc. (CRIS) Q3 2023 Earnings Call Transcript

Nov 2, 2023, 2:32 PM EDT - 1 year ago

Curis, Inc. (CRIS) Q3 2023 Earnings Call Transcript


Curis Provides Third Quarter 2023 Business Update

Nov 2, 2023, 8:00 AM EDT - 1 year ago

Curis Provides Third Quarter 2023 Business Update


Curis Announces Date for the 2nd Symposium on IRAK4 in Cancer

Sep 12, 2023, 8:00 AM EDT - 2 years ago

Curis Announces Date for the 2nd Symposium on IRAK4 in Cancer


Curis, Inc. (CRIS) Q2 2023 Earnings Call Transcript

Aug 3, 2023, 9:35 PM EDT - 2 years ago

Curis, Inc. (CRIS) Q2 2023 Earnings Call Transcript


Curis Provides Second Quarter 2023 Business Update

Aug 3, 2023, 4:01 PM EDT - 2 years ago

Curis Provides Second Quarter 2023 Business Update


Curis Announces $15.1 Million Registered Direct Offering

Jul 6, 2023, 8:00 AM EDT - 2 years ago

Curis Announces $15.1 Million Registered Direct Offering


Curis, Inc. (CRIS) Q1 2023 Earnings Call Transcript

May 4, 2023, 9:59 PM EDT - 2 years ago

Curis, Inc. (CRIS) Q1 2023 Earnings Call Transcript


Curis Provides First Quarter 2023 Business Update

May 4, 2023, 4:01 PM EDT - 2 years ago

Curis Provides First Quarter 2023 Business Update


Curis, Inc. (CRIS) Q4 2022 Earnings Call Transcript

Mar 13, 2023, 12:22 PM EDT - 2 years ago

Curis, Inc. (CRIS) Q4 2022 Earnings Call Transcript


Curis Provides Fourth Quarter 2022 Business Update

Mar 13, 2023, 8:00 AM EDT - 2 years ago

Curis Provides Fourth Quarter 2022 Business Update


Topzero
Topzero Aug. 1 at 8:35 PM
$CRIS Believe me the company garbage Also, CEO Soon new TARGET 0
0 · Reply
LodiDodiWeLikesToParty
LodiDodiWeLikesToParty Jul. 31 at 11:26 AM
$CRIS I don't believe they even have a product anymore. Total silence. This has to be fraud.
0 · Reply
Topzero
Topzero Jul. 30 at 6:39 PM
$CRIS don’t believe this company believe me 6 years same story this is company cheats
0 · Reply
Topzero
Topzero Jul. 30 at 6:36 PM
$CRIS soon OTC
0 · Reply
Yodalay
Yodalay Jul. 30 at 1:39 PM
August 5, Q2 results $CRIS
0 · Reply
BallWasher69
BallWasher69 Jul. 28 at 9:53 AM
$CRIS two weeks or less until we receive a corporate update via their Q2 financial release….
0 · Reply
View2021
View2021 Jul. 23 at 3:15 AM
$CRIS breakout stock tomorrow $1.50
0 · Reply
baaaddbob
baaaddbob Jul. 22 at 3:47 PM
$CRIS most analysts expect this stock to go to $17 or above?.. ask chat gpt….. loaded up just now$$
0 · Reply
Topzero
Topzero Jul. 21 at 7:30 PM
$CRIS I told you before — this company is trash, and the stock will be split soon. Do not buy it! Beware, even if it goes up, it’s just a trap — their last desperate move to steal your money.”
0 · Reply
Topzero
Topzero Jul. 21 at 5:47 AM
$CRIS Advice to All Investors: If the stock price of Curis Inc. (CRIS) rises, do not rush to buy. Be cautious, as purchasing the stock during an upward movement may lead to it being “locked in” at a high price. This could allow the company to accumulate a significant amount of capital. Subsequently, the company might perform a stock split, which could benefit them at your expense. Avoid buying altogether to shift the responsibility entirely onto the company. Let them bear the burden of raising the stock price on their own. However, if you do buy shares and the price is lifted—only for the company to sell a large volume and then execute a stock split—the company will profit. The stock’s value may appear to multiply, but this could be a trap. Do not be deceived by the company’s actions. Insist that they take full responsibility for raising the stock price, and avoid falling into a scenario where their gains come at your loss.
0 · Reply
CmonManGiveMeABreak
CmonManGiveMeABreak Jul. 20 at 2:08 AM
$CRIS pos is always pos
0 · Reply
MethOsillyOmar
MethOsillyOmar Jul. 18 at 11:42 PM
$SGMO $CSPR $SRPT $CRIS $LLY Looks like Sarepta is toast with FDA putting all genetherapy trials on hold. MethO will go for a juicy T-bone instead tonight. 💎🤩🥩
1 · Reply
Pipelinepivots
Pipelinepivots Jul. 18 at 7:05 PM
RSLS is the type of biotech play that goes vertical before most even react. You’ve got a confirmed merger, an ultra-low float, and a sub-$1 price tag. No dilution hanging over it, no crowd just structure, silence, and a trigger waiting to hit. These are the ones that gap up 100–300% in a blink. $CRIS $MEIP $APTO $CTXR
0 · Reply
Topzero
Topzero Jul. 17 at 5:02 AM
$CRIS We all know that these companies are built on fraud, manipulating us by issuing shares to collect as much money as possible before shutting down without providing any value. They steal our money and speak in the name of treatment, exploiting the leniency of American markets that allow such practices while everyone covers for each other. If these companies were in Gulf countries, they wouldn’t have succeeded in doing this. The coming years will witness more blatant theft.
0 · Reply
LodiDodiWeLikesToParty
LodiDodiWeLikesToParty Jul. 17 at 2:00 AM
$CRIS the sad thing is, the article sounds fantastic, but big pharma has no interest in curing anything. I am a fool for believing that this will ever come to market. I invested $16K in this shit hole and is now worth only $400. They have been spitting out the old crap for the past 4 years and they will continue to do the same to secure their exuberant paychecks for producing nothing. Probably working towards another reverse split. POS!!!!
0 · Reply
MaiXin
MaiXin Jul. 16 at 5:06 PM
$CRIS https://www.nature.com/articles/s41375-025-02695-3 Great artical and conclusion! ‚In conclusion, our findings demonstrate the therapeutic potential of combining IRAK4 inhibitors with GSPT1-targeting CELMoDs, such as CC-885, to overcome resistance mechanisms and improve treatment outcomes in AML. This work highlights the importance of rational combination therapies and sets the stage for further mechanistic and translational studies to optimize IRAK4-targeted approaches in these malignancies.“
1 · Reply
UCD_12dd
UCD_12dd Jul. 15 at 1:17 PM
$CRIS 11% drop premarket, why, why, why???
0 · Reply
LodiDodiWeLikesToParty
LodiDodiWeLikesToParty Jul. 12 at 12:03 AM
$CRIS If my heart monitor looked like this, I would have been declared dead a long time ago.
0 · Reply
Topzero
Topzero Jul. 11 at 7:42 PM
$CRIS They sold more than 650,000 shares today; this is evidence that they will proceed with a stock split. The best way is to escape. 🚀🚀
0 · Reply
Yodalay
Yodalay Jul. 11 at 3:12 PM
$CRIS Huge volume this morning. Funny how news makes it over the wall a few days before we hear about it.
2 · Reply
Topzero
Topzero Jul. 11 at 3:11 PM
$CRIS The escape from this stock is the best thing—it’s terrifying. I expect a mass exodus from the company.
0 · Reply
View2021
View2021 Jul. 10 at 5:32 PM
$CRIS building position This will Make a run to $5
0 · Reply